Hair Transplantation in Cicatricial Alopecias
January 2013
in “
Hair therapy & transplantation
”
Studysummary This review discusses surgical and future therapeutic options for cicatricial alopecia and reports no clinical results; the authors emphasize the need for more options for patients without active disease signs. Our plain-language summary of this paper — not a Tressless recommendation.
The document from 2013 reviewed treatment options for cicatricial alopecia (CA), a type of hair loss characterized by scarring. It differentiated between primary CA, with unknown causes, and secondary CA, resulting from trauma or inflammation. The document highlighted surgical treatments like hair transplantation, specifically the Follicular Unit Extraction (FUE) method, as well as excision, flap surgery, and tissue expansion. It emphasized the importance of blood flow in the recipient area for the success of hair transplantation. Additionally, the document mentioned the use of minoxidil and pentoxyphylline to enhance graft survival and the future potential of hair neogenesis using autologous adult hair follicle cells. It also acknowledged complications such as ischemia, tissue necrosis, and infection, recommending that patients without active disease should have access to more therapeutic options.